TrialReader


Hypercapnic Burden in Adults With Obesity Undergoing Diagnostic Polysomnography for Suspected Obstructive Sleep Apnea

NCT07809061 — Not applicable, Not yet recruiting, 150 participants, Hospices Civils de Lyon

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Hypercapnic Burden in Adults With Obesity Undergoing Diagnostic Polysomnography for Suspected Obstructive Sleep Apnea: A Prospective Observational Cohort Study

RegistryNCT07809061, acronym HBO-POSA
StatusNot yet recruiting
PhaseNot applicable
Study typeInterventional; na, single group, masking: none, diagnostic
Enrollment150 (Estimated)
SponsorHospices Civils de Lyon (Other)
ConditionsObstructive Sleep Apnea, Obesity (BMI>30), Obesity Hypoventilation Syndrome (OHS), Sleep Hypoventilation
InterventionsSleep Inertia Questionnaire (SIQ) (Behavioral)
Datesstart 2026-11-01 (estimated), primary completion 2028-11-03 (estimated), completion 2028-11-03 (estimated), first posted 2026-09-09, last updated 2026-09-09
Locations1 site in France

Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Obstructive Sleep Apnea All trials for Obesity (BMI>30) All trials of Sleep Inertia Questionnaire (SIQ)

-Summary

Obesity-related sleep hypoventilation represents a continuum ranging from isolated nocturnal hypoventilation to obesity hypoventilation syndrome. Current diagnostic criteria rely mainly on dichotomous thresholds and may not adequately reflect cumulative nocturnal carbon dioxide exposure.

Hypercapnic burden, defined as the cumulative area under the transcutaneous carbon dioxide (PtcCO₂) curve above a predefined threshold, has recently emerged as a novel physiological marker integrating both the intensity and duration of nocturnal hypercapnia.

This prospective observational cohort study aims to evaluate the association between nocturnal hypercapnic burden and obstructive sleep apnea severity, assessed by the apnea-hypopnea index (AHI), in adults with obesity referred for diagnostic polysomnography.

Secondary objectives include evaluating associations between hypercapnic burden and sleep architecture, respiratory events, oxygenation parameters, daytime symptoms, and patient-reported outcomes. In addition, the study will investigate the relationship between nocturnal hypercapnic burden and sleep inertia, assessed using the Sleep Inertia Questionnaire (SIQ), based on the hypothesis that greater nocturnal carbon dioxide exposure immediately before awakening may contribute to impaired alertness upon awakening.

Hypothesis: Increased nocturnal hypercapnic burden is associated with greater obstructive sleep apnea severity and reflects an additional physiological dimension of obesity-related sleep hypoventilation beyond conventional polysomnographic indices. Furthermore, higher nocturnal hypercapnic burden is hypothesized to be associated with greater sleep inertia.

Expand all sections  ·  Collapse all

+Arms and interventions

ArmTypeInterventionsDescription
Adults with obesity referred for diagnostic polysomnographyExperimentalBehavioral: Sleep Inertia Questionnaire (SIQ)Adults with obesity (body mass index ≥30 kg/m²) referred to the Sleep Medicine Center for routine diagnostic polysomnography because of suspected obstructive sleep apnea
  • Sleep Inertia Questionnaire (SIQ) (Behavioral): The only research-specific procedure is the completion of the Sleep Inertia Questionnaire (SIQ), a self-administered questionnaire requiring approximately 5 minutes to complete and performed once after the diagnostic sleep study.

+Outcome measures

Primary outcomes

  • Correlation between nocturnal hypercapnic burden and apnea-hypopnea index [Baseline only (overnight diagnostic polysomnography)]: Correlation between nocturnal hypercapnic burden above 45 mmHg (HB45), defined as the area under the nocturnal transcutaneous carbon dioxide pressure (PtcCO₂) curve above 45 mmHg and normalized per hour of recording (mmHg·min/hour), and the apnea-hypopnea index derived from diagnostic polysomnography (events/hour). The correlation will be assessed using Pearson's or Spearman's correlation coefficient, according to data distribution.

+Eligibility

Sex: All, ages: 18 Years to any

Inclusion Criteria:

* Age ≥18 years.
* Body mass index (BMI) ≥30 kg/m².
* Referred to the Sleep Medicine Center for routine diagnostic polysomnography because of suspected obstructive sleep apnea.
* Affiliated with a French health insurance scheme.
* Received information about the study and did not object to the use of their data.
* Able to understand the study information and complete study questionnaires.

Exclusion Criteria:

* Legal incapacity or inability to provide non-opposition to participation.
* Previous treatment with continuous positive airway pressure (CPAP) or non-invasive ventilation.
* Participation in another interventional clinical study that could interfere with the present study.

+Locations (1)

FacilityCityCountryStatus
Croix-Rousse Hospital, Hospices Civils de LyonLyonFrance

My Notes